Volume 68, Issue 5, Pages (November 2015)

Slides:

Advertisements

Similar presentations

European Urology Focus

Advertisements

Volume 57, Issue 3, Pages (March 2010)

Early Detection of Prostate Cancer in 2007

Volume 56, Issue 5, Pages (November 2009)

Impact of LUTS Using Bother Index in DAN-PSS-1 Questionnaire

Volume 55, Issue 1, Pages 1-8 (January 2009)

Volume 72, Issue 1, Pages (July 2017)

Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit Pim J. van Leeuwen, David Connolly, Anna.

Volume 164, Issue 6, Pages (December 2000)

Volume 41, Issue 6, Pages (June 2002)

Volume 70, Issue 3, Pages (September 2016)

Volume 45, Issue 5, Pages (May 2004)

Volume 54, Issue 2, Pages (August 2008)

Volume 68, Issue 6, Pages (December 2015)

Volume 57, Issue 1, Pages (January 2010)

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

Volume 51, Issue 2, Pages (February 2007)

Volume 62, Issue 5, Pages (November 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 4, Pages (October 2010)

Testosterone Therapy in Men With Prostate Cancer

Global Trends in Testicular Cancer Incidence and Mortality

Volume 53, Issue 4, Pages (April 2008)

Volume 61, Issue 5, Pages (May 2012)

Volume 67, Issue 4, Pages (April 2015)

Volume 53, Issue 5, Pages (May 2008)

Volume 51, Issue 4, Pages (April 2007)

Volume 70, Issue 4, Pages (October 2016)

Volume 61, Issue 2, Pages (February 2012)

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

Volume 61, Issue 3, Pages (March 2012)

Volume 63, Issue 4, Pages (April 2013)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

Volume 59, Issue 4, Pages (April 2011)

Prostate Cancer Detection: A View of the Future

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 66, Issue 3, Pages (September 2014)

Volume 66, Issue 6, Pages (December 2014)

Prostate Cancer Epidemic in Sight?

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 4, Pages (April 2008)

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Volume 71, Issue 1, Pages (January 2017)

Volume 65, Issue 6, Pages (June 2014)

Volume 68, Issue 4, Pages (October 2015)

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Volume 48, Issue 6, Pages (December 2005)

Volume 64, Issue 4, Pages (October 2013)

Volume 50, Issue 5, Pages (November 2006)

Volume 58, Issue 3, Pages (September 2010)

Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Testicular Cancer Variations in Time and Space in Europe

Volume 59, Issue 4, Pages (April 2011)

Volume 72, Issue 1, Pages (July 2017)

European Urology is “Your” Journal

Volume 65, Issue 6, Pages (June 2014)

European Urology Oncology

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review Fritz Schröder,

Volume 52, Issue 6, Pages (December 2007)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Volume 51, Issue 2, Pages (February 2007)

Volume 54, Issue 3, Pages (September 2008)

Volume 52, Issue 5, Pages (November 2007)

Volume 76, Issue 1, Pages (July 2019)

Presentation transcript:

Volume 68, Issue 5, Pages 885-890 (November 2015) Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer Carlotta Buzzoni, Anssi Auvinen, Monique J. Roobol, Sigrid Carlsson, Sue M. Moss, Donella Puliti, Harry J. de Koning, Chris H. Bangma, Louis J. Denis, Maciej Kwiatkowski, Marcos Lujan, Vera Nelen, Alvaro Paez, Marco Randazzo, Xavier Rebillard, Teuvo L.J. Tammela, Arnauld Villers, Jonas Hugosson, Fritz H. Schröder, Marco Zappa European Urology Volume 68, Issue 5, Pages 885-890 (November 2015) DOI: 10.1016/j.eururo.2015.02.042 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Cumulative incidence rate ratios for risk category 4 (after data imputation) and cumulative prostate cancer mortality rate ratio by time since randomisation (95% confidence intervals given in parentheses). IRD=incidence rate difference per 1000 randomised men; MRD=mortality rate difference per 1000 randomised men. European Urology 2015 68, 885-890DOI: (10.1016/j.eururo.2015.02.042) Copyright © 2015 European Association of Urology Terms and Conditions